Literature DB >> 9635904

Drug-induced uveitis.

R S Moorthy1, S Valluri, L M Jampol.   

Abstract

Uveitis has been reported in association with a variety of topical, intraocular, periocular, and systemic medications. To establish causality of adverse events by drugs, in 1981, Naranjo and associates proposed seven criteria, which are related to the frequency and documentation of the event; circumstances of occurrence, recovery, and recurrence; and coexistence of other factors or medications. Rarely does a drug meet all seven criteria. The authors review reports of drug-associated uveitis, applying the seven criteria and examining possible mechanisms. Only systemically administered biphosphonates and, perhaps, topical metipranolol meet all seven criteria. Systemic sulfonamides, rifabutin, and topical glucocorticoids fulfill at least five criteria.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9635904     DOI: 10.1016/s0039-6257(97)00130-6

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  13 in total

Review 1.  Advances in the diagnosis and immunotherapy for ocular inflammatory disease.

Authors:  Steven Yeh; Lisa J Faia; Robert B Nussenblatt
Journal:  Semin Immunopathol       Date:  2008-03-05       Impact factor: 9.623

2.  The effect of previous surgery and topical eye drops for primary open-angle glaucoma on cytokine expression in aqueous humor.

Authors:  Lisa A Engel; Philipp S Muether; Sascha Fauser; Arno Hueber
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-03-18       Impact factor: 3.117

Review 3.  Chronic non-infectious uveitis in the elderly: epidemiology, pathophysiology and management.

Authors:  Rajen Gupta; Philip I Murray
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

4.  Late-onset Ocular Toxicity Presenting as Uveitis Caused by Crizotinib.

Authors:  Megumi Iseki; Toshikatsu Kaburaki; Makoto Aihara; Hiromasa Sawamura
Journal:  Neuroophthalmology       Date:  2021-05-06

5.  Acute anterior uveitis following intravitreal bevacizumab but not subsequent ranibizumab.

Authors:  Christina Antonopoulos; Maxwell Stem; Grant M Comer
Journal:  Clin Ophthalmol       Date:  2011-11-24

Review 6.  Tubulointerstitial nephritis and uveitis (TINU) syndrome: a systematic review of its epidemiology, demographics and risk factors.

Authors:  Linda O Okafor; Peter Hewins; Philip I Murray; Alastair K Denniston
Journal:  Orphanet J Rare Dis       Date:  2017-07-14       Impact factor: 4.123

7.  Trabeculotomy ab interno with Trabectome as surgical management for systemic fluoroquinolone-induced pigmentary glaucoma: A case report.

Authors:  Kyle A Den Beste; Constance Okeke
Journal:  Medicine (Baltimore)       Date:  2017-10       Impact factor: 1.889

8.  Marginal structural model to evaluate the association between cumulative osteoporosis medication and infection using claims data.

Authors:  F Xue; V Goli; P Petraro; T McMullan; J M Sprafka; E J Tchetgen Tchetgen
Journal:  Osteoporos Int       Date:  2017-07-06       Impact factor: 4.507

9.  Drug-induced uveitis.

Authors:  Nikolas Js London; Sunir J Garg; Ramana S Moorthy; Emmett T Cunningham
Journal:  J Ophthalmic Inflamm Infect       Date:  2013-03-25

10.  A Rare Cause of Uveitis: Vemurafenib

Authors:  Selçuk Sızmaz; Nuhkan Görkemli; Ebru Esen; Nihal Demircan
Journal:  Turk J Ophthalmol       Date:  2018-12-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.